I agree Warp, as this new asset surprise should quiet down many of the constant questioners and naysayers. We really have no idea what goes on behind closed doors, as this was 18 months in the making and we heard about it yesterday afternoon. Just what information we're the new people (who hired on these past 12 months) shown ? I would imagine it was extremely impressive or they might not have come onboard to a start-up, otc traded biotech with no current revenues.
I guess GC never mentioned ESS to Dave L. In all the conversations Dave always references to.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links